BeyondSpring Inc. (BYSI)
NASDAQ: BYSI · Real-Time Price · USD
1.340
-0.010 (-0.74%)
Mar 2, 2026, 10:22 AM EST - Market open
BeyondSpring Market Cap
BeyondSpring has a market cap or net worth of $55.1 million as of March 2, 2026. Its market cap has decreased by -19.56% in one year.
Market Cap
55.10M
Enterprise Value
43.30M
1-Year Change
-19.56%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since March 9, 2017, BeyondSpring's market cap has decreased from $362.10M to $55.10M, a decrease of -84.78%. That is a compound annual growth rate of -18.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 54.40M | -17.20% |
| Dec 31, 2025 | 65.70M | - |
| Dec 31, 2024 | 65.70M | 87.18% |
| Dec 29, 2023 | 35.10M | -52.05% |
| Dec 30, 2022 | 73.20M | -58.71% |
| Dec 31, 2021 | 177.30M | -52.38% |
| Dec 31, 2020 | 372.30M | -7.48% |
| Dec 31, 2019 | 402.40M | -4.76% |
| Dec 31, 2018 | 422.50M | -32.59% |
| Dec 29, 2017 | 626.80M | 73.10% |
| Mar 9, 2017 | 362.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 59.28M |
| Mereo BioPharma Group | 58.97M |
| Spruce Biosciences | 58.81M |
| Metagenomi Therapeutics | 57.07M |
| Lipocine | 55.30M |
| Nutriband | 53.97M |
| Plus Therapeutics | 53.55M |
| Tevogen Bio Holdings | 53.24M |